Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 28

1.

Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries.

Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Nikšić M, Bonaventure A, Valkov M, Johnson CJ, Estève J, Ogunbiyi OJ, Azevedo E Silva G, Chen WQ, Eser S, Engholm G, Stiller CA, Monnereau A, Woods RR, Visser O, Lim GH, Aitken J, Weir HK, Coleman MP; CONCORD Working Group.

Lancet. 2018 Mar 17;391(10125):1023-1075. doi: 10.1016/S0140-6736(17)33326-3. Epub 2018 Jan 31.

PMID:
29395269
2.

Erratum to "Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2)" [Gynecol. Oncol. 144 (2017) 396-404].

Matz M, Coleman MP, Carreira H, Salmerón D, Chirlaque MD, Allemani C; CONCORD Working Group.

Gynecol Oncol. 2017 Dec;147(3):725. doi: 10.1016/j.ygyno.2017.06.033. Epub 2017 Jul 5. No abstract available.

PMID:
28688523
3.

Erratum to "The histology of ovarian cancer: Worldwide distribution and implications for international survival comparisons (CONCORD-2)" [Gynecol. Oncol. 144 (2017) 405-413].

Matz M, Coleman MP, Sant M, Chirlaque MD, Visser O, Gore M, Allemani C; CONCORD Working Group; Africa.

Gynecol Oncol. 2017 Dec;147(3):726. doi: 10.1016/j.ygyno.2017.06.032. Epub 2017 Jul 5. No abstract available.

PMID:
28687170
4.

Worldwide comparison of survival from childhood leukaemia for 1995-2009, by subtype, age, and sex (CONCORD-2): a population-based study of individual data for 89 828 children from 198 registries in 53 countries.

Bonaventure A, Harewood R, Stiller CA, Gatta G, Clavel J, Stefan DC, Carreira H, Spika D, Marcos-Gragera R, Peris-Bonet R, Piñeros M, Sant M, Kuehni CE, Murphy MFG, Coleman MP, Allemani C; CONCORD Working Group.

Lancet Haematol. 2017 May;4(5):e202-e217. doi: 10.1016/S2352-3026(17)30052-2. Epub 2017 Apr 11. Erratum in: Lancet Haematol. 2017 May;4(5):e201.

5.

The histology of ovarian cancer: worldwide distribution and implications for international survival comparisons (CONCORD-2).

Matz M, Coleman MP, Sant M, Chirlaque MD, Visser O, Gore M, Allemani C; & the CONCORD Working Group.

Gynecol Oncol. 2017 Feb;144(2):405-413. doi: 10.1016/j.ygyno.2016.10.019. Epub 2016 Dec 6. Erratum in: Gynecol Oncol. 2017 Dec;147(3):726.

6.

Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2).

Matz M, Coleman MP, Carreira H, Salmerón D, Chirlaque MD, Allemani C; CONCORD Working Group.

Gynecol Oncol. 2017 Feb;144(2):396-404. doi: 10.1016/j.ygyno.2016.11.019. Epub 2016 Dec 2. Erratum in: Gynecol Oncol. 2017 Dec;147(3):725.

7.

Position statement from the European Board and College of Obstetrics & Gynaecology (EBCOG): The use of medicines during pregnancy - call for action.

Van Calsteren K, Gersak K, Sundseth H, Klingmann I, Dewulf L, Van Assche A, Mahmood T.

Eur J Obstet Gynecol Reprod Biol. 2016 Jun;201:189-91. doi: 10.1016/j.ejogrb.2016.04.004. Epub 2016 Apr 9.

PMID:
27132709
8.

Position Statement from the European Board and College of Obstetrics & Gynaecology (EBCOG) : The use of medicines during pregnancy: call for action.

Van Calsteren K, Gersak K, Sundseth H, Klingmann I, Dewulf L, Van Assche A, Mahmood T.

Eur J Obstet Gynecol Reprod Biol. 2016 Jun;201:211-4. doi: 10.1016/j.ejogrb.2016.04.016. Epub 2016 Apr 25. Review.

PMID:
27132708
9.

Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2).

Allemani C, Weir HK, Carreira H, Harewood R, Spika D, Wang XS, Bannon F, Ahn JV, Johnson CJ, Bonaventure A, Marcos-Gragera R, Stiller C, Azevedo e Silva G, Chen WQ, Ogunbiyi OJ, Rachet B, Soeberg MJ, You H, Matsuda T, Bielska-Lasota M, Storm H, Tucker TC, Coleman MP; CONCORD Working Group.

Lancet. 2015 Mar 14;385(9972):977-1010. doi: 10.1016/S0140-6736(14)62038-9. Epub 2014 Nov 26. Erratum in: Lancet. 2015 Mar 14;385(9972):946.

10.

Descriptive epidemiology of Kaposi sarcoma in Europe. Report from the RARECARE project.

Stiller CA, Trama A, Brewster DH, Verne J, Bouchardy C, Navarro C, Chirlaque MD, Marcos-Gragera R, Visser O, Serraino D, Weiderpass E, Dei Tos AP, Ascoli V; RARECARE Working Group.

Cancer Epidemiol. 2014 Dec;38(6):670-8. doi: 10.1016/j.canep.2014.09.009. Epub 2014 Oct 22.

PMID:
25454979
11.

Methodological aspects of estimating rare cancer prevalence in Europe: the experience of the RARECARE project.

Mallone S, De Angelis R, van der Zwan JM, Trama A, Siesling S, Gatta G, Capocaccia R; RARECARE WG.

Cancer Epidemiol. 2013 Dec;37(6):850-6. doi: 10.1016/j.canep.2013.08.001. Epub 2013 Sep 16.

PMID:
24050903
12.

Rare neuroendocrine tumours: results of the surveillance of rare cancers in Europe project.

van der Zwan JM, Trama A, Otter R, Larrañaga N, Tavilla A, Marcos-Gragera R, Dei Tos AP, Baudin E, Poston G, Links T; RARECARE WG.

Eur J Cancer. 2013 Jul;49(11):2565-78. doi: 10.1016/j.ejca.2013.02.029. Epub 2013 Mar 27.

PMID:
23541566
13.

Incidence, survival and prevalence of myeloid malignancies in Europe.

Visser O, Trama A, Maynadié M, Stiller C, Marcos-Gragera R, De Angelis R, Mallone S, Tereanu C, Allemani C, Ricardi U, Schouten HC; RARECARE Working Group.

Eur J Cancer. 2012 Nov;48(17):3257-66. doi: 10.1016/j.ejca.2012.05.024. Epub 2012 Jul 4.

PMID:
22770878
14.

Rare thoracic cancers, including peritoneum mesothelioma.

Siesling S, van der Zwan JM, Izarzugaza I, Jaal J, Treasure T, Foschi R, Ricardi U, Groen H, Tavilla A, Ardanaz E; RARECARE Working Group.

Eur J Cancer. 2012 May;48(7):949-60. doi: 10.1016/j.ejca.2012.02.047. Epub 2012 Mar 9.

PMID:
22406029
15.

Carcinoma of endocrine organs: results of the RARECARE project.

van der Zwan JM, Mallone S, van Dijk B, Bielska-Lasota M, Otter R, Foschi R, Baudin E, Links TP; RARECARE WG.

Eur J Cancer. 2012 Sep;48(13):1923-31. Epub 2012 Feb 21.

PMID:
22361014
16.

Embryonal cancers in Europe.

Gatta G, Ferrari A, Stiller CA, Pastore G, Bisogno G, Trama A, Capocaccia R; RARECARE Working Group.

Eur J Cancer. 2012 Jul;48(10):1425-33. doi: 10.1016/j.ejca.2011.12.027. Epub 2012 Feb 20.

PMID:
22357215
17.

Epidemiology of glial and non-glial brain tumours in Europe.

Crocetti E, Trama A, Stiller C, Caldarella A, Soffietti R, Jaal J, Weber DC, Ricardi U, Slowinski J, Brandes A; RARECARE working group.

Eur J Cancer. 2012 Jul;48(10):1532-42. doi: 10.1016/j.ejca.2011.12.013. Epub 2012 Jan 7.

PMID:
22227039
18.

Incidence, prevalence and survival of patients with rare epithelial digestive cancers diagnosed in Europe in 1995-2002.

Faivre J, Trama A, De Angelis R, Elferink M, Siesling S, Audisio R, Bosset JF, Cervantes A, Lepage C; RARECARE Working Group.

Eur J Cancer. 2012 Jul;48(10):1417-24. doi: 10.1016/j.ejca.2011.10.038. Epub 2011 Dec 9.

PMID:
22169462
19.

Burden of testicular, paratesticular and extragonadal germ cell tumours in Europe.

Trama A, Mallone S, Nicolai N, Necchi A, Schaapveld M, Gietema J, Znaor A, Ardanaz E, Berrino F; RARECARE Working Group.

Eur J Cancer. 2012 Jan;48(2):159-69. doi: 10.1016/j.ejca.2011.08.020. Epub 2011 Dec 3. Erratum in: Eur J Cancer. 2013 Feb;49(3):766.

PMID:
22142457
20.

Descriptive epidemiology of malignant mucosal and uveal melanomas and adnexal skin carcinomas in Europe.

Mallone S, De Vries E, Guzzo M, Midena E, Verne J, Coebergh JW, Marcos-Gragera R, Ardanaz E, Martinez R, Chirlaque MD, Navarro C, Virgili G; RARECARE WG.

Eur J Cancer. 2012 May;48(8):1167-75. doi: 10.1016/j.ejca.2011.10.004. Epub 2011 Nov 25.

PMID:
22119735

Supplemental Content

Loading ...
Support Center